Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryoko Yamada

Showing results (81-90 of 85) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 85 results.
Journal of Gastroenterology|November 12, 2014
Impact of alpha-fetoprotein on hepatocellular carcinoma development during entecavir treatment of chronic hepatitis B virus infectionRyoko Yamada, Naoki Hiramatsu, Tsugiko Oze, et al.
Journal of Gastroenterology and Hepatology|September 9, 2025
Hypertension as an Adverse Event Potentially Impacting the Therapeutic Efficacy of Atezolizumab Plus Bevacizumab in Patients With Unresectable Hepatocellular CarcinomaKazuki Maesaka, Hayato Hikita, Machiko Kai, et al.
Journal of Gastroenterology|October 1, 2020
Sofosbuvir plus velpatasvir treatment for hepatitis C virus in patients with decompensated cirrhosis: a Japanese real-world multicenter studyYuki Tahata, Hayato Hikita, Satoshi Mochida, et al.
Journal of Gastroenterology|January 21, 2022
Liver-related events after direct-acting antiviral therapy in patients with hepatitis C virus-associated cirrhosisYuki Tahata, Hayato Hikita, Satoshi Mochida, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 16, 2025
The Risk of Developing Hepatocellular Carcinoma Persists in Chronic Hepatitis B Patients Even After the Long-Term Administration of Nucleos(t)ide AnalogsKazuhiro Murai, Hayato Hikita, Ryoko Yamada, et al.
Pageof 9

Showing results (81-90 of 85) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 85 results.
Journal of Gastroenterology|November 12, 2014
Impact of alpha-fetoprotein on hepatocellular carcinoma development during entecavir treatment of chronic hepatitis B virus infectionRyoko Yamada, Naoki Hiramatsu, Tsugiko Oze, et al.
Journal of Gastroenterology and Hepatology|September 9, 2025
Hypertension as an Adverse Event Potentially Impacting the Therapeutic Efficacy of Atezolizumab Plus Bevacizumab in Patients With Unresectable Hepatocellular CarcinomaKazuki Maesaka, Hayato Hikita, Machiko Kai, et al.
Journal of Gastroenterology|October 1, 2020
Sofosbuvir plus velpatasvir treatment for hepatitis C virus in patients with decompensated cirrhosis: a Japanese real-world multicenter studyYuki Tahata, Hayato Hikita, Satoshi Mochida, et al.
Journal of Gastroenterology|January 21, 2022
Liver-related events after direct-acting antiviral therapy in patients with hepatitis C virus-associated cirrhosisYuki Tahata, Hayato Hikita, Satoshi Mochida, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 16, 2025
The Risk of Developing Hepatocellular Carcinoma Persists in Chronic Hepatitis B Patients Even After the Long-Term Administration of Nucleos(t)ide AnalogsKazuhiro Murai, Hayato Hikita, Ryoko Yamada, et al.
Pageof 9